Opioid free anaesthesia for coronary revascularization surgery and its effect on post-operative recovery- An observational prospective study
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
- 试验地点
- 1
- 主要终点
- To explore the efficacy of Opioid free anaesthesia in coronary vascularisation surgeries by assessing the quality of anesthesia, postoperative pain levels and adverse effects.
研究概览
简要总结
Coronary revascularization surgery, a common procedure for the treatment of coronary artery disease, is traditionally associated with significant postoperative pain and opioid consumption. However, the use of opioids in the perioperative period can lead to a range of adverse effects, including respiratory depression, sedation, and the development of chronic opioid use. (Schwenk et al., 2018) To address these concerns, researchers have explored the feasibility and efficacy of opioid-free anesthesia for coronary revascularization surgery and its impact on postoperative recovery.
One of the key potential benefits of opioid-free anesthesia is the reduction in opioid consumption during the perioperative period. Studies have shown that the use of alternative analgesic agents, such as ketamine, can effectively manage pain without the need for high doses of opioids. Ketamine, an N-methyl-D-aspartate receptor antagonist, has been found to have analgesic properties and can be used in combination with other non-opioid medications to provide effective pain control. (Schwenk et al., 2018) Furthermore, the use of opioid-free anesthesia may have a positive impact on postoperative recovery, as it can reduce the incidence of opioid-related side effects, such as respiratory depression, sedation, and the development of chronic opioid use. (Hah et al., 2021). In a case report, researchers described the successful use of oral ketamine to treat opioid-resistant postoperative pain, highlighting the potential of this approach to reduce opioid requirements and improve pain management (Friedman et al., 2001).
In summary, the transition to opioid-free anesthesia for coronary revascularization surgeries introduces significant benefits that warrant further exploration and implementation. This approach mitigates the risks associated with opioid use, such as addiction potential and adverse side effects, while still addressing the critical need for effective pain management. Additionally, the importance of a thorough preoperative evaluation ties closely into the decision-making processes around anesthesia options, emphasizing the need for tailored approaches in clinical settings (Adams et al.). Ultimately, embracing opioid-free techniques not only aligns with emerging standards
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 盲法
- None
入排标准
- 年龄范围
- 18.00 Year(s) 至 75.00 Year(s)(—)
- 性别
- All
入选标准
- •1.Good Left Ventricle Function Greater than 45 percentage Ejection Fraction.
- •2.No History of stroke, Central Nervous System disorders, any psychiatric medications 3.Adult patients 18 to 75 years old.
- •4.Scheduled for an elective Coronary Artery Bypass Graft.
- •5.Patient consent to participate in the study.
排除标准
- •1.Reduced Left Ventricle function less than 45 percentage Ejection Fraction.
- •2.Known history of opioid abuse.
- •3.Bradycardia less than 50 beats per minute.
- •Heart blocks greater than 2nd degree.
- •4.Contraindication to one of the trial drugs (dexmedetomidine, lidocaine, Magnesium sulphate, ketamine, non- steroidal anti- inflammatory drugs 5.Body mass index greater than or equal to 35 kg per meter square.
- •6.Combined cardiac surgeries other than aortic valve replacement.
- •7.Cognitive disorders.
- •8.Patients refusal consent.
结局指标
主要结局
To explore the efficacy of Opioid free anaesthesia in coronary vascularisation surgeries by assessing the quality of anesthesia, postoperative pain levels and adverse effects.
时间窗: At the end of study duration data will be collected study duration 12 months
次要结局
- 1.To assess the Haemodynamic response to intubation and surgery including incidence of bradycardia in the patients.(2.To assess the efficacy of the nerve blocks in terms of postoperative pain scores.)
研究者
Dr Geetha Muniraju
Fortis Hospital Limited
